The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis

Journal of the Neurological Sciences

Volumn 294, Issue 1-2, 2010, Pages 74-80

  Liu, Hua ^a,b   Yang, Min ^c   Li, Guang Ming ^a   Qiu, Ya ^a   Zheng, Jian ^b   Du, Xin ^a   Wang, Ji Liang ^a   Liu, Ruo Wei ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

Gene polymorphism; Meta analysis; Methylenetetrahydrofolate reductase; MTHFR; Systematic review; VaD; Vascular dementia; VD

Indexed keywords

ARTICLE; ASIAN; CAUCASIAN; CLINICAL TRIAL; GENOTYPE; HUMAN; META ANALYSIS; MULTIINFARCT DEMENTIA; POPULATION; PRIORITY JOURNAL; PUBLICATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

ASIAN CONTINENTAL ANCESTRY GROUP; DEMENTIA, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC;

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

EID: 77953284657     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.04.001     Document Type: Article

References (56)

1. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005) 2112-2117
2. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357 (2001) 169-175
3. Román G.C. The epidemiology of vascular dementia. Handb Clin Neurol. 89 (2008) 639-658
4. Román G.C. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 203-204 (2002) 7-10
5. Knopman D.S., Rocca W.A., Cha R.H., Edland S.D., and Kokmen E. Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol 60 (2003) 85-90
6. Hassan A., and Markus H.S. Genetics and ischaemic stroke. Brain 123 (2000) 1784-1812
7. Knopman D.S. Dementia and cerebrovascular disease. Mayo Clin Proc 81 (2006) 223-230
8. Liu H., Liu M., Li W., Wu B., Zhang S.H., Fang Y., et al. Association of ACE I/D gene polymorphism with vascular dementia: a meta-analysis. J Geriatr Psychiatry Neurol 22 (2009) 10-22
9. Nilsson K., Gustafson L., and Hultberg B. Plasma homocysteine levels and different forms of vascular disease in patients with dementia and other psychogeriatric diseases. Dement Geriatr Cogn Disord 27 (2009) 88-95
10. Vogel T., Dali-Youcef N., Kaltenbach G., and Andrès E. Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 63 (2009) 1061-1067
11. Köseoglu E.K., and Karaman Y. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Clin Biochem 40 (2007) 859-863
12. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
13. Elkins J.S., Johnston S.C., Ziv E., Kado D., Cauley J.A., and Yaffe K. Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in older women. Am J Epidemiol 166 (2007) 672-678
14. Thakkinstian A., McElduff P., D'Este C., Duffy D., and Attia J. A method for meta-analysis of molecular association studies. Stat Med 24 (2005) 1291-1306
15. Munafò M.R., and Flint J. Meta-analysis of genetic association studies. Trends Genet 20 (2004) 439-444
16. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
17. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
18. Berman N.G., and Parker R.A. Meta-analysis: neither quick nor easy. BMC Med Res Methodol 2 (2002) 10
19. Higgins J., Thompson S., Deeks J., and Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 7 (2002) 51-61
20. Higgins J.P., and Thompson S.E. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
21. Emigh T.H. A comparison of tests for Hardy-Weinberg equilibrium. Biometrics 36 (1980) 627-642
22. Harbord R.M., Egger M., and Sterne J.A. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25 (2006) 3443-3457
23. Zintzaras E., and Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61 (2008) 634-645
24. Ioannidis J.P., Ntzani E.E., and Trikalinos T.A. "Racial" differences in genetic effects for complex diseases. Nat Genet 36 (2004) 1312-1318
25. Ikeda M., Hokoishi K., Maki N., Nebu A., Tachibana N., Komori K., et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology 57 (2001) 839-844
26. Aguilar B., Rojas J.C., and Collados M.T. Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolysis 18 (2004) 75-87
27. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
28. Chapman J., Wang N.S., Treves T.A., Korczyn A.D., and Bornstein N.M. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 29 (1998) 1401-1404
29. Pollak R.D., Pollak A., Idelson M., Bejarano-Achache I., Doron D., and Blumenfeld A. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc 48 (2000) 64-68
30. Bottiglieri T., Parnetti L., Arning E., Ortiz T., Amici S., Lanari A., et al. Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mech Ageing Dev 122 (2001) 2013-2023
31. Zuliani G., Blé A., Zanca R., Munari M.R., Zurlo A., Vavalle C., et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scand 103 (2001) 304-308
32. McIlroy S.P., Dynan K.B., Lawson J.T., Patterson C.C., and Passmore A.P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in northern Ireland. Stroke 33 (2002) 2351-2356
33. Wehr H., Bednarska-Makaruk M., Łojkowska W., Graban A., Hoffman-Zacharska D., Kuczyńska-Zardzewiały A., et al. Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dement Geriatr Cogn Disord 22 (2006) 1-7
34. Nishiyama M., Kato Y., Hashimoto M., Yukawa S., and Omori K. Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia-an epidemiological study using the polymerase chain reaction (PCR) method. J Epidemiol 10 (2000) 163-172
35. Yoo J.H., Choi G.D., and Kang S.S. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 20 (2000) 1921-1925
36. Wu D.B., Wang L.N., YE L., Liu J.W., and Wang L. Analysis of MTHFR C677T polymorphism in patients with SAD and VD. Chin J Neuro Med(Chinese) 5 (2006) 775-780
37. Sun YN, Zhang BS. Common research between AD and VaD-relationship between Alzheimer disease and vascular dementia on the homocysteine and fibrinogen [dissertation]. Tianjin (China): Tianjin Medical University; 2008.
38. Pandey P., Pradhan S., Modi D.R., and Mittal B. MTHFR and ACE gene polymorphisms and risk of vascular and degenerative dementias in the elderly. Brain Cogn 71 (2009) 295-299
39. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., Schouten E.G., et al. MTHFR 677C - > T polymorphism and risk of coronary heart disease - a meta-analysis. JAMA 288 (2002) 2023-2031
40. Ariyaratnam R., Casas J.P., Whittaker J., Smeeth L., Hingorani A.D., and Sharma P. Genetics of ischemic stroke among persons of non-European descent: a meta-analysis of eight genes involving 32500 individuals. Plos Med 4 (2007) 728-736
41. Xin X.Y., Song Y.Y., Ma J.F., Fan C.N., Ding J.Q., Yang G.Y., et al. Gene polymorphisms and risk of adult early-onset ischemic stroke: a meta-analysis. Thromb Res 124 (2009) 619-624
42. Qian X.Q., Lu Z.G., Tan M., Liu H., and Lu D. meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur J Hum Genet 15 (2007) 1239-1245
43. Zintzaras E., Uhlig K., Koukoulis G.N., Papathanasiou A.A., and Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 52 (2007) 881-890
44. Gorgone G., Ursini F., Altamura C., Bressi F., Tombini M., Curcio G., et al. Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: a correlation study in patients with cognitive impairment. Atherosclerosis 206 (2009) 309-313
45. Lewis S.J., Ebrahim S., and Davy Smith G. Meta-analysis of MTHFR 677C- > T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. BMJ 331 (2005) 1053
46. Banerjee I., Gupta V., and Gan S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 52 (2007) 205-219
47. Xu X.W., Li J.J., Sheng W.L., and Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis 26 (2008) 48-62
48. Zondervan K.T., and Cardon L.R. The complex interplay among factors that influence allelic association. Nat Rev Genet 5 (2004) 89-100
49. Langevin S.M., Lin D., Matsuo K., Gao C.M., Takezaki T., Stolzenberg-Solomon R.Z., et al. Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett 184 (2009) 73-80
50. Román G.C., Sachdev P., Royall D.R., Bullock R.A., Orgogozo J.M., López-Pousa S., et al. Vascular cognitive disorder: a new diagnostic category updating, vascular cognitive impairment and vascular dementia. J Neurol Sci 226 (2004) 81-87
51. Nakamizo T., and Nagayama M. Stroke and the genetics of hyperhomocysteinemia. Brain Nerve (Shinkei kenkyu no shinpo) 60 (2008) 1295-1306
52. Eker E.L., Ertan T., Engin F., Sazci A., Ergul E., Akpinar G., et al. MTHFR polymorphism in patients with vascular dementia. Am J Hum Genet 73 5 Suppl (2003) 374
53. Chaudhuri J.R., Kamalesh C., Rajesh A., Varma R., Mohan V., Ishwarchandra C., et al. Homocysteinemia in vascular dementia: role of C677T mutation in the methyl tehralydrofolate reductase gene: a study from India. J Neurol Sci 229 (2005) 313-314 [Sp. Iss. SI]
54. McCullagh C.D. An investigation of inflammatory and vascular genetic risk factors for stroke and dementia following stroke [dissertation] (2004), Queen's University of Belfast, Belfast, Northern Ireland (United Kingdom)
55. Tysoe C., Galinsky D., Robinson D., Brayne C.E., Easton D.F., Huppert F.A., et al. Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Genet 74 (1997) 207-212
56. Ravaglia G., Forti P., Maioli F., Scali R.C., Arnone G., Talerico T., et al. Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern italian subjects. Arch Gerontol Geriatr Suppl 9 (2004) 339-348